SCHEDULE 13G/A: Vanguard Group Amends Stake in Health Catalyst, Disclosing 5.88% Beneficial Ownership
Beneficial Ownership Report
The Vanguard Group has filed an Amendment No. 7 to its Schedule 13G, reporting a 5.88% beneficial ownership stake in Health Catalyst Inc. as of March 31, 2025.
Summary
- The Vanguard Group, a Pennsylvania-based investment adviser, filed an Amendment No. 7 to its Schedule 13G regarding its beneficial ownership in Health Catalyst Inc.
- As of March 31, 2025, Vanguard beneficially owns an aggregate of 4,131,653 shares of Health Catalyst Inc. Common Stock.
- This ownership represents 5.88% of the class of securities.
- Vanguard holds sole dispositive power over 4,082,252 shares and shared dispositive power over 49,401 shares.
- Vanguard holds sole voting power over 0 shares and shared voting power over 28,612 shares.
- The filing certifies that the securities were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing control of the issuer.
Sentiment
Score: 5
Explanation: Neutral, as this is a routine disclosure of beneficial ownership by a passive institutional investor, providing no performance or strategic insights about the issuer.
Future Outlook
This Schedule 13G filing is a disclosure of beneficial ownership and does not contain forward-looking statements or guidance regarding the issuer's future performance or strategic outlook.
Industry Context
This filing indicates The Vanguard Group's continued passive investment in Health Catalyst Inc., a company operating in the healthcare technology and data analytics sector. As a major institutional investor, Vanguard's stake reflects its portfolio allocation decisions within the broader market.
Stakeholder Impact
- Shareholders: Provides transparency regarding a significant institutional investor's stake, which can influence market perception and liquidity.
Key Dates
| Date | Description |
|---|---|
| 03/31/2025 | Date of event which requires filing of this statement (reporting date for beneficial ownership). |
| 04/30/2025 | Date of filing of this Schedule 13G Amendment No. 7. |
Keywords
Health Catalyst Inc., Vanguard Group, Schedule 13G, beneficial ownership, common stock, institutional investor, SEC filing, healthcare technology
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.